Uses and limitations of monoclonal antibodies (MoAbs) in the treatment of malignant disease: a review.

Gelijkaardige items

• Effect of chlorpromazine on kinetics of injected monoclonal antibody in MoAb-induced glomerular injury.
  door: Takashima, N, et al.
  Gepubliceerd in: (1993)
• Human follicular dendritic cells (FDC): a study with monoclonal antibodies (MoAb).
  door: Johnson, G D, et al.
  Gepubliceerd in: (1986)
• Use of MoAb D612 in combination with a panel of MoAb for the immunocytochemical identification of metastases from colon-rectum carcinoma.
  door: Mottolese, M., et al.
  Gepubliceerd in: (1990)
• The role of EGFR monoclonal antibodies (MoABs) cetuximab/panitumab, and BRAF inhibitors in BRAF mutated colorectal cancer
  door: Muhammad, Shan, et al.
  Gepubliceerd in: (2013)
• A murine monoclonal antibody, MoAb HMSA-5, against a melanosomal component highly expressed in early stages, and common to normal and neoplastic melanocytes.
  door: Der, J. E., et al.
  Gepubliceerd in: (1993)